ARCHIVES

NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group

This article is from The Cancer Letter archive.

Vol. 21 No. 05 | February 3, 1995

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

June 30, 2006

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

Study: Lack of Sleep Linked With Agressive Breast Cancers

September 28, 2012

To nurture staff, NCI plans an academy.

February 13, 2004

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

ASCO Letter To NCI Urges Increased Support for Clinical Trials, Training, Translational Research

March 6, 2009